PRME - Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference | Benzinga
CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will participate in a panel discussion at the 27th Annual Milken Institute Global Conference entitled "Things That Will Blow Your Mind." The panel will bring together innovators across multiple disciplines to discuss cutting-edge technologies, inventions, and scientific breakthroughs, and to share a glimpse of what the future will look like.
The Conference will take place May 5-8, 2024, in Los Angeles, California and the panel discussion will be held on Wednesday, May 8, 2024, at 8:30 a.m. PT ...